Targeting mutant p53 for cancer therapy: direct and indirect strategies.
Hu J, Cao J, Topatana W, Juengpanich S, Li S, Zhang B, Shen J, Cai L, Cai X, Chen M.
Hu J, et al. Among authors: cao j.
J Hematol Oncol. 2021 Sep 28;14(1):157. doi: 10.1186/s13045-021-01169-0.
J Hematol Oncol. 2021.
PMID: 34583722
Free PMC article.
Review.